The chemotherapy of tuberculous meningitis in children and adults (Q37784590)

23 August 2017

The chemotherapy of tuberculous meningitis in children and adults (English)

1 reference

23 August 2017

1 reference

1 reference

tuberculous meningitis

1 reference

P R Donald

1

1 reference

23 August 2017

1 November 2010

1 reference

23 August 2017

1 reference

23 August 2017

90

1 reference

23 August 2017

6

1 reference

23 August 2017

375-392

1 reference

Novel wide-range quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA: clinical application for diagnosis of tuberculous meningitis

23 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Clinical, cerebrospinal fluid and pathological findings and outcomes in HIV-positive and HIV-negative patients with tuberculous meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Treatment of tuberculous meningitis with streptomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

7 January 2021

Tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

The treatment of tuberculous meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

The present status of the treatment of tuberculosis of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis in children. A review of 167 untreated and 74 treated patients with special reference to early diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis in children treated with streptomycin and P.A.S.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

C.S.F.--isoniazid levels in tuberculous meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

The treatment of tuberculous meningitis in infants with streptomycin and isonicotinic acid hydrazide (isoniazid); a preliminary report of six patients under the age of two years treated without intrathecal medication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculosis of the central nervous system in children: a 20-year survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis: special features of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis treated with ACTH and isoniazid; a comparison with intrathecal streptomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Treatment of tuberculous meningitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis since the introduction of isoniazid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis: a review of 51 cases in Madras.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Evaluation of corticosteroids in treatment of tuberculous meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis in children during the isoniazid era

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis in childhood. Forty-three cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

7 January 2021

Tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

The use of dexamethasone in preventing ocular complications in tuberculous meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Dexamethasone adjunctive treatment for tuberculous meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

The treatment of tuberculous meningitis in children with a combination of isoniazid, rifampicin and streptomycin—preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Treatment of tuberculous meningitis in adults with a combination of isoniazid, rifampicin and streptomycin: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Short-term antimicrobial treatment of tuberculous meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 month

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Three chemotherapy studies of tuberculous meningitis in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis in children: treatment with isoniazid and rifampicin for twelve months.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis. Short course of chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Factors of prognostic significance in Chinese children with tuberculous meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Clinical and public health aspects of tuberculous meningitis in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Treatment of tuberculous meningitis in Turkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis in adults: review of 48 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis among adults with and without HIV infection. Experience in an urban public hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis at a large inner-city medical center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis in children: clinical features and outcome in 40 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

The prognostic factors of adult tuberculous meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis in adults--experience from Turkey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

The high mortality rate associated with tuberculous meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Short-course chemotherapy for extrapulmonary tuberculosis. Nine years' experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Evidence behind the WHO guidelines: hospital care for children: what is the most appropriate anti-microbial treatment for tuberculous meningitis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Cerebrospinal Fluid Concentrations of Rifampin in Meningeal Tuberculosis1,2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Cerebrospinal fluid pyrazinamide concentrations in children with tuberculous meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Ethambutol in Tuberculous Meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

The early bactericidal activity of anti-tuberculosis drugs: a literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Ofloxacin penetration into cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Diffusion of ofloxacin into cerebrospinal fluid of patients with purulent meningitis or ventriculitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Plasma and cerebrospinal fluid pharmacokinetics of moxifloxacin in a patient with tuberculous meningitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Ethionamide: its passage into the cerebrospinal fluid in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Cerebrospinal fluid concentrations of ethionamide in children with tuberculous meningitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Primary drug-resistant tuberculosis in children. Correlation of drug-susceptibility patterns of matched patient and source case strains of Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

The treatment of tuberculous meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Central nervous system tuberculosis after resolution of miliary tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Evolution of central nervous system multidrug-resistant Mycobacterium tuberculosis and late relapse of cryptic prosthetic hip joint tuberculosis: complications during treatment of disseminated isoniazid-resistant tuberculosis in an immunocompromised

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis and co-infection with HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis in patients infected with the human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis in patients with and without human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis in South African urban adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculous meningitis in HIV-infected patients: drug susceptibility and clinical outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Drug resistant tuberculous meningitis in the Philippines: report of a case.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Tuberculosis in health care workers at a hospital with an outbreak of multidrug-resistant Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Multidrug-resistant tuberculous meningitis in children in Durban, South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Multidrug-resistant tuberculous meningitis in an HIV-positive patient: a challenging disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Consensus statement on childhood tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

Central nervous system tuberculosis in children: a review of 30 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.07.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TUBE.2010.07.003

1 reference

23 August 2017

1 reference

PubMed ID

20810322